Risedronate Therapy for the Prevention of Steroid-Induced Osteoporosis in Patients With Minimal-Change Nephrotic Syndrome

Internal Medicine - Japan
doi 10.2169/internalmedicine.49.3707
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Quality of Life in Patients With Minimal Change Nephrotic Syndrome

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

1522 Evidence of Chronic Renal Damage in Patients With Steroid Dependent Minimal Change Disease (Mcd) Nephrotic Syndrome

Pediatric Research
Child HealthPediatricsPerinatology
1981English

Minimal Change Nephrotic Syndrome and Cyclophosphamide.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1987English

The Level of Urinary Semaphorin3A Is Associated With Disease Activity in Patients With Minimal Change Nephrotic Syndrome

International Journal of Nephrology and Renovascular Disease
Nephrology
2017English

Staphylococcal Scalded Skin Syndrome in a Child With Nephrotic Syndrome on Steroid Therapy

Annals of International medical and Dental Research
2017English

1624 Paucity of Minimal Change (Mc) Lesion in Young Children With Early Frequently Relapsing Steroid Sensitive (Frss) Nephrotic Syndrome (Ns)

Pediatric Research
Child HealthPediatricsPerinatology
1985English

Long-Term Therapy With Cyclosporine and Alternate-Day Prednisone in Patients With Idiopathic Steroid Resistant Nephrotic Syndrome (SRNS)

Pediatric Review: International Journal of Pediatric Research
2018English

Nephrotic Syndrome Induced by Gold Therapy.

BMJ
1970English

OC8 High Prevalence Ofwt1gene Mutations in Patients With Steroid-Resistant Nephrotic Syndrome

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy